Abstract
This article addresses the issues that are raised when implementing Prograf as a new primary immunosuppressive agent. It focuses on the nurses' role in pre- and post-operative management, with an emphasis on patient assessment/monitoring and education.
| Original language | English |
|---|---|
| Pages (from-to) | 14-18 |
| Number of pages | 5 |
| Journal | EDTNA/ERCA Journal |
| Volume | 24 |
| Issue number | 2 |
| Publication status | Published - Apr 1998 |